Active Shortage

TAMIFLU

HOFFMANN-LA ROCHE LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TAMIFLU in Canada?

Yes. TAMIFLU 6MG has an active shortage reported to Health Canada (last updated October 27, 2026).

Why is TAMIFLU not available?

The reason the manufacturer reported: Demand increase for the drug.

When will TAMIFLU be available again?

The manufacturer's estimated resolution date is December 1, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file4 products · 0 same form & route

Expected resolution~19 days remaining (estimate)

Affected strength6MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

TAMIFLU

HOFFMANN-LA ROCHE LIMITED

75MG · DIN 02241472

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

JAMP OSELTAMIVIR

JAMP PHARMA CORPORATION

30MG · DIN 02497409

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SANDOZ OSELTAMIVIR

SANDOZ CANADA INCORPORATED

45MG · DIN 02504014

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MINT-OSELTAMIVIR

MINT PHARMACEUTICALS INC

30MG · DIN 02497441

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02381842

Strength

6MG

Dosage Form

POWDER FOR SUSPENSION

Route

ORAL

Active Ingredient

OSELTAMIVIR

See all OSELTAMIVIR products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-10-27

Active Shortage

Demand increase for the drug.

2018-02-28

Shortage Avoided

Demand increase for the drug.

Other Products from HOFFMANN-LA ROCHE LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

162MG · DIN 02424770

200MG · DIN 02350106

400MG · DIN 02350114

162MG · DIN 02483327

80MG · DIN 02350092

DIN 02147440